![](https://investorshub.advfn.com/uicon/522650.png?cb=1464431304)
Sunday, April 11, 2021 1:39:48 PM
Oh but don't you see n2k...if Nasrat would have just been selling these opioids the whole time Elite would've made $100 million in revenue by now and we'd all be rich. We definitely wouldn't have been sued and gone under.
Hope I don't need the sarcasm button for this one. ;)
Where this post fails in sarcasm, it succeeds in irony. The sad fact is that had Norco and Percocet been commercialized in a timely fashion, we very well could have $100 million in revenue by now. Likewise, it is extremely unlikely Elite would have been sued, just like every other small to mid-size generic pharma who continue to manufacture and sell opioid products in a highly-regulated market.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157514121
no2koolaid Monday, 08/10/20 04:53:54 PM
Post # 341031 of 351823
Percocet: 16 competitors with equal prorated market share of 6.25%/500 = 31.250 M
Norco: 11 competitors with equal prorated market share of 0.91% / 447 = 40.680 M
Ty w/code: 8 competitors with equal prorated market share of 12.5% / 45 = 5.630 M
Methadone: 10 competitors with equal prorated market share of = 10.0% / 30 = 3.00 M
Hydromorphone: 8 competitors with equal prorated market share of = 12.5% / 30 = 3.750 M
In aggregate, the prorated market share for an owner of the drugs at peak would be more than $50M, it would be = $84.310 M.
Occam's razor: the simplest solution is most likely the right one.
Hanlon's razor: never attribute to malice that which is adequately explained by stupidity.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM